Accelerating AAV to the Clinic with Purification Improvements

Genetic Engineering & Biotechnology NewsVol. 39, No. 12 Bioprocess TutorialAccelerating AAV to the Clinic with Purification ImprovementsBIA Separations describes how developers may cope with chromatin contamination and improve the separation of full and empty capsidsPete GagnonPete GagnonPete Gagnon is the chief scientific officer of BIA Separations. Website: www.biaseparations.com.Search for more papers by this authorPublished Online:3 Dec 2019https://doi.org/10.1089/gen.39.12.16AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 39Issue 12Dec 2019 Information© 2019 by GEN PublishingTo cite this article:Pete Gagnon.Accelerating AAV to the Clinic with Purification Improvements.Genetic Engineering & Biotechnology News.Dec 2019.59-61.http://doi.org/10.1089/gen.39.12.16Published in Volume: 39 Issue 12: December 3, 2019PDF download